ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
2
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
2
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Computational Drug Discovery Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-3Y6233
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Computational Drug Discovery Market Insights Forecast to 2028
BUY CHAPTERS

Global Computational Drug Discovery Market Research Report 2025

Code: QYRE-Auto-3Y6233
Report
July 2025
Pages:86
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
AMRI
Charles River
Schrödinger
Evotec AG
Bayers
GVK Biosciences
Astrazeneca plc
Bioduro LLC
Boc Sciences
Aris Pharmaceuticals
RTI International
XRQTC
Pharmaron

Computational Drug Discovery Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Computational Drug Discovery Market

Computational Drug Discovery Market

The global market for Computational Drug Discovery was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Computational Drug Discovery/Computer-Aided Drug Discovery is an effective strategy for accelerating and economizing drug discovery and development process. Because of the dramatic increase in the availability of biological macromolecule and small molecule information, the applicability of computational drug discovery has been extended and broadly applied to nearly every stage in the drug discovery and development workflow, including target identification and validation, lead discovery and optimization and preclinical tests. Over the past decades, computational drug discovery methods such as molecular docking, pharmacophore modeling and mapping, de novo design, molecular similarity calculation and sequence-based virtual screening have been greatly improved.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Computational Drug Discovery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Computational Drug Discovery.
The Computational Drug Discovery market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Computational Drug Discovery market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Computational Drug Discovery companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Computational Drug Discovery Market Report

Report Metric Details
Report Name Computational Drug Discovery Market
CAGR 5%
Segment by Type
  • Structure-based Drug Design (SBDD)
  • Ligand-based Drug Design (LBDD)
  • Sequence-based Approaches
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company AMRI, Charles River, Schrödinger, Evotec, Bayers, GVK Biosciences, AstraZeneca, BioDuro, BOC Sciences, Aris Pharmaceuticals, ChemDiv, RTI International, XRQTC, Pharmaron
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Computational Drug Discovery company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Computational Drug Discovery Market report?

Ans: The main players in the Computational Drug Discovery Market are AMRI, Charles River, Schrödinger, Evotec, Bayers, GVK Biosciences, AstraZeneca, BioDuro, BOC Sciences, Aris Pharmaceuticals, ChemDiv, RTI International, XRQTC, Pharmaron

What are the Application segmentation covered in the Computational Drug Discovery Market report?

Ans: The Applications covered in the Computational Drug Discovery Market report are Oncological Disorders, Neurological Disorders, Immunological Disorders, Infectious Diseases, Others

What are the Type segmentation covered in the Computational Drug Discovery Market report?

Ans: The Types covered in the Computational Drug Discovery Market report are Structure-based Drug Design (SBDD), Ligand-based Drug Design (LBDD), Sequence-based Approaches

Recommended Reports

Drug Discovery Software

Pharmaceutical AI & Data

Drug Delivery & Safety

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Computational Drug Discovery Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Structure-based Drug Design (SBDD)
1.2.3 Ligand-based Drug Design (LBDD)
1.2.4 Sequence-based Approaches
1.3 Market by Application
1.3.1 Global Computational Drug Discovery Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Oncological Disorders
1.3.3 Neurological Disorders
1.3.4 Immunological Disorders
1.3.5 Infectious Diseases
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Computational Drug Discovery Market Perspective (2020-2031)
2.2 Global Computational Drug Discovery Growth Trends by Region
2.2.1 Global Computational Drug Discovery Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Computational Drug Discovery Historic Market Size by Region (2020-2025)
2.2.3 Computational Drug Discovery Forecasted Market Size by Region (2026-2031)
2.3 Computational Drug Discovery Market Dynamics
2.3.1 Computational Drug Discovery Industry Trends
2.3.2 Computational Drug Discovery Market Drivers
2.3.3 Computational Drug Discovery Market Challenges
2.3.4 Computational Drug Discovery Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Computational Drug Discovery Players by Revenue
3.1.1 Global Top Computational Drug Discovery Players by Revenue (2020-2025)
3.1.2 Global Computational Drug Discovery Revenue Market Share by Players (2020-2025)
3.2 Global Computational Drug Discovery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Computational Drug Discovery Revenue
3.4 Global Computational Drug Discovery Market Concentration Ratio
3.4.1 Global Computational Drug Discovery Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Computational Drug Discovery Revenue in 2024
3.5 Global Key Players of Computational Drug Discovery Head office and Area Served
3.6 Global Key Players of Computational Drug Discovery, Product and Application
3.7 Global Key Players of Computational Drug Discovery, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Computational Drug Discovery Breakdown Data by Type
4.1 Global Computational Drug Discovery Historic Market Size by Type (2020-2025)
4.2 Global Computational Drug Discovery Forecasted Market Size by Type (2026-2031)
5 Computational Drug Discovery Breakdown Data by Application
5.1 Global Computational Drug Discovery Historic Market Size by Application (2020-2025)
5.2 Global Computational Drug Discovery Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Computational Drug Discovery Market Size (2020-2031)
6.2 North America Computational Drug Discovery Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Computational Drug Discovery Market Size by Country (2020-2025)
6.4 North America Computational Drug Discovery Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Computational Drug Discovery Market Size (2020-2031)
7.2 Europe Computational Drug Discovery Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Computational Drug Discovery Market Size by Country (2020-2025)
7.4 Europe Computational Drug Discovery Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Computational Drug Discovery Market Size (2020-2031)
8.2 Asia-Pacific Computational Drug Discovery Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Computational Drug Discovery Market Size by Region (2020-2025)
8.4 Asia-Pacific Computational Drug Discovery Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Computational Drug Discovery Market Size (2020-2031)
9.2 Latin America Computational Drug Discovery Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Computational Drug Discovery Market Size by Country (2020-2025)
9.4 Latin America Computational Drug Discovery Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Computational Drug Discovery Market Size (2020-2031)
10.2 Middle East & Africa Computational Drug Discovery Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Computational Drug Discovery Market Size by Country (2020-2025)
10.4 Middle East & Africa Computational Drug Discovery Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AMRI
11.1.1 AMRI Company Details
11.1.2 AMRI Business Overview
11.1.3 AMRI Computational Drug Discovery Introduction
11.1.4 AMRI Revenue in Computational Drug Discovery Business (2020-2025)
11.1.5 AMRI Recent Development
11.2 Charles River
11.2.1 Charles River Company Details
11.2.2 Charles River Business Overview
11.2.3 Charles River Computational Drug Discovery Introduction
11.2.4 Charles River Revenue in Computational Drug Discovery Business (2020-2025)
11.2.5 Charles River Recent Development
11.3 Schrödinger
11.3.1 Schrödinger Company Details
11.3.2 Schrödinger Business Overview
11.3.3 Schrödinger Computational Drug Discovery Introduction
11.3.4 Schrödinger Revenue in Computational Drug Discovery Business (2020-2025)
11.3.5 Schrödinger Recent Development
11.4 Evotec
11.4.1 Evotec Company Details
11.4.2 Evotec Business Overview
11.4.3 Evotec Computational Drug Discovery Introduction
11.4.4 Evotec Revenue in Computational Drug Discovery Business (2020-2025)
11.4.5 Evotec Recent Development
11.5 Bayers
11.5.1 Bayers Company Details
11.5.2 Bayers Business Overview
11.5.3 Bayers Computational Drug Discovery Introduction
11.5.4 Bayers Revenue in Computational Drug Discovery Business (2020-2025)
11.5.5 Bayers Recent Development
11.6 GVK Biosciences
11.6.1 GVK Biosciences Company Details
11.6.2 GVK Biosciences Business Overview
11.6.3 GVK Biosciences Computational Drug Discovery Introduction
11.6.4 GVK Biosciences Revenue in Computational Drug Discovery Business (2020-2025)
11.6.5 GVK Biosciences Recent Development
11.7 AstraZeneca
11.7.1 AstraZeneca Company Details
11.7.2 AstraZeneca Business Overview
11.7.3 AstraZeneca Computational Drug Discovery Introduction
11.7.4 AstraZeneca Revenue in Computational Drug Discovery Business (2020-2025)
11.7.5 AstraZeneca Recent Development
11.8 BioDuro
11.8.1 BioDuro Company Details
11.8.2 BioDuro Business Overview
11.8.3 BioDuro Computational Drug Discovery Introduction
11.8.4 BioDuro Revenue in Computational Drug Discovery Business (2020-2025)
11.8.5 BioDuro Recent Development
11.9 BOC Sciences
11.9.1 BOC Sciences Company Details
11.9.2 BOC Sciences Business Overview
11.9.3 BOC Sciences Computational Drug Discovery Introduction
11.9.4 BOC Sciences Revenue in Computational Drug Discovery Business (2020-2025)
11.9.5 BOC Sciences Recent Development
11.10 Aris Pharmaceuticals
11.10.1 Aris Pharmaceuticals Company Details
11.10.2 Aris Pharmaceuticals Business Overview
11.10.3 Aris Pharmaceuticals Computational Drug Discovery Introduction
11.10.4 Aris Pharmaceuticals Revenue in Computational Drug Discovery Business (2020-2025)
11.10.5 Aris Pharmaceuticals Recent Development
11.11 ChemDiv
11.11.1 ChemDiv Company Details
11.11.2 ChemDiv Business Overview
11.11.3 ChemDiv Computational Drug Discovery Introduction
11.11.4 ChemDiv Revenue in Computational Drug Discovery Business (2020-2025)
11.11.5 ChemDiv Recent Development
11.12 RTI International
11.12.1 RTI International Company Details
11.12.2 RTI International Business Overview
11.12.3 RTI International Computational Drug Discovery Introduction
11.12.4 RTI International Revenue in Computational Drug Discovery Business (2020-2025)
11.12.5 RTI International Recent Development
11.13 XRQTC
11.13.1 XRQTC Company Details
11.13.2 XRQTC Business Overview
11.13.3 XRQTC Computational Drug Discovery Introduction
11.13.4 XRQTC Revenue in Computational Drug Discovery Business (2020-2025)
11.13.5 XRQTC Recent Development
11.14 Pharmaron
11.14.1 Pharmaron Company Details
11.14.2 Pharmaron Business Overview
11.14.3 Pharmaron Computational Drug Discovery Introduction
11.14.4 Pharmaron Revenue in Computational Drug Discovery Business (2020-2025)
11.14.5 Pharmaron Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
AMRI
Charles River
Schrödinger
Evotec AG
Bayers
GVK Biosciences
Astrazeneca plc
Bioduro LLC
Boc Sciences
Aris Pharmaceuticals
RTI International
XRQTC
Pharmaron
List of Tables
 Table 1. Global Computational Drug Discovery Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Structure-based Drug Design (SBDD)
 Table 3. Key Players of Ligand-based Drug Design (LBDD)
 Table 4. Key Players of Sequence-based Approaches
 Table 5. Global Computational Drug Discovery Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Computational Drug Discovery Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Computational Drug Discovery Market Size by Region (2020-2025) & (US$ Million)
 Table 8. Global Computational Drug Discovery Market Share by Region (2020-2025)
 Table 9. Global Computational Drug Discovery Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 10. Global Computational Drug Discovery Market Share by Region (2026-2031)
 Table 11. Computational Drug Discovery Market Trends
 Table 12. Computational Drug Discovery Market Drivers
 Table 13. Computational Drug Discovery Market Challenges
 Table 14. Computational Drug Discovery Market Restraints
 Table 15. Global Computational Drug Discovery Revenue by Players (2020-2025) & (US$ Million)
 Table 16. Global Computational Drug Discovery Market Share by Players (2020-2025)
 Table 17. Global Top Computational Drug Discovery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Computational Drug Discovery as of 2024)
 Table 18. Ranking of Global Top Computational Drug Discovery Companies by Revenue (US$ Million) in 2024
 Table 19. Global 5 Largest Players Market Share by Computational Drug Discovery Revenue (CR5 and HHI) & (2020-2025)
 Table 20. Global Key Players of Computational Drug Discovery, Headquarters and Area Served
 Table 21. Global Key Players of Computational Drug Discovery, Product and Application
 Table 22. Global Key Players of Computational Drug Discovery, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global Computational Drug Discovery Market Size by Type (2020-2025) & (US$ Million)
 Table 25. Global Computational Drug Discovery Revenue Market Share by Type (2020-2025)
 Table 26. Global Computational Drug Discovery Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 27. Global Computational Drug Discovery Revenue Market Share by Type (2026-2031)
 Table 28. Global Computational Drug Discovery Market Size by Application (2020-2025) & (US$ Million)
 Table 29. Global Computational Drug Discovery Revenue Market Share by Application (2020-2025)
 Table 30. Global Computational Drug Discovery Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 31. Global Computational Drug Discovery Revenue Market Share by Application (2026-2031)
 Table 32. North America Computational Drug Discovery Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 33. North America Computational Drug Discovery Market Size by Country (2020-2025) & (US$ Million)
 Table 34. North America Computational Drug Discovery Market Size by Country (2026-2031) & (US$ Million)
 Table 35. Europe Computational Drug Discovery Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. Europe Computational Drug Discovery Market Size by Country (2020-2025) & (US$ Million)
 Table 37. Europe Computational Drug Discovery Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Asia-Pacific Computational Drug Discovery Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Asia-Pacific Computational Drug Discovery Market Size by Region (2020-2025) & (US$ Million)
 Table 40. Asia-Pacific Computational Drug Discovery Market Size by Region (2026-2031) & (US$ Million)
 Table 41. Latin America Computational Drug Discovery Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Latin America Computational Drug Discovery Market Size by Country (2020-2025) & (US$ Million)
 Table 43. Latin America Computational Drug Discovery Market Size by Country (2026-2031) & (US$ Million)
 Table 44. Middle East & Africa Computational Drug Discovery Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Middle East & Africa Computational Drug Discovery Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Middle East & Africa Computational Drug Discovery Market Size by Country (2026-2031) & (US$ Million)
 Table 47. AMRI Company Details
 Table 48. AMRI Business Overview
 Table 49. AMRI Computational Drug Discovery Product
 Table 50. AMRI Revenue in Computational Drug Discovery Business (2020-2025) & (US$ Million)
 Table 51. AMRI Recent Development
 Table 52. Charles River Company Details
 Table 53. Charles River Business Overview
 Table 54. Charles River Computational Drug Discovery Product
 Table 55. Charles River Revenue in Computational Drug Discovery Business (2020-2025) & (US$ Million)
 Table 56. Charles River Recent Development
 Table 57. Schrödinger Company Details
 Table 58. Schrödinger Business Overview
 Table 59. Schrödinger Computational Drug Discovery Product
 Table 60. Schrödinger Revenue in Computational Drug Discovery Business (2020-2025) & (US$ Million)
 Table 61. Schrödinger Recent Development
 Table 62. Evotec Company Details
 Table 63. Evotec Business Overview
 Table 64. Evotec Computational Drug Discovery Product
 Table 65. Evotec Revenue in Computational Drug Discovery Business (2020-2025) & (US$ Million)
 Table 66. Evotec Recent Development
 Table 67. Bayers Company Details
 Table 68. Bayers Business Overview
 Table 69. Bayers Computational Drug Discovery Product
 Table 70. Bayers Revenue in Computational Drug Discovery Business (2020-2025) & (US$ Million)
 Table 71. Bayers Recent Development
 Table 72. GVK Biosciences Company Details
 Table 73. GVK Biosciences Business Overview
 Table 74. GVK Biosciences Computational Drug Discovery Product
 Table 75. GVK Biosciences Revenue in Computational Drug Discovery Business (2020-2025) & (US$ Million)
 Table 76. GVK Biosciences Recent Development
 Table 77. AstraZeneca Company Details
 Table 78. AstraZeneca Business Overview
 Table 79. AstraZeneca Computational Drug Discovery Product
 Table 80. AstraZeneca Revenue in Computational Drug Discovery Business (2020-2025) & (US$ Million)
 Table 81. AstraZeneca Recent Development
 Table 82. BioDuro Company Details
 Table 83. BioDuro Business Overview
 Table 84. BioDuro Computational Drug Discovery Product
 Table 85. BioDuro Revenue in Computational Drug Discovery Business (2020-2025) & (US$ Million)
 Table 86. BioDuro Recent Development
 Table 87. BOC Sciences Company Details
 Table 88. BOC Sciences Business Overview
 Table 89. BOC Sciences Computational Drug Discovery Product
 Table 90. BOC Sciences Revenue in Computational Drug Discovery Business (2020-2025) & (US$ Million)
 Table 91. BOC Sciences Recent Development
 Table 92. Aris Pharmaceuticals Company Details
 Table 93. Aris Pharmaceuticals Business Overview
 Table 94. Aris Pharmaceuticals Computational Drug Discovery Product
 Table 95. Aris Pharmaceuticals Revenue in Computational Drug Discovery Business (2020-2025) & (US$ Million)
 Table 96. Aris Pharmaceuticals Recent Development
 Table 97. ChemDiv Company Details
 Table 98. ChemDiv Business Overview
 Table 99. ChemDiv Computational Drug Discovery Product
 Table 100. ChemDiv Revenue in Computational Drug Discovery Business (2020-2025) & (US$ Million)
 Table 101. ChemDiv Recent Development
 Table 102. RTI International Company Details
 Table 103. RTI International Business Overview
 Table 104. RTI International Computational Drug Discovery Product
 Table 105. RTI International Revenue in Computational Drug Discovery Business (2020-2025) & (US$ Million)
 Table 106. RTI International Recent Development
 Table 107. XRQTC Company Details
 Table 108. XRQTC Business Overview
 Table 109. XRQTC Computational Drug Discovery Product
 Table 110. XRQTC Revenue in Computational Drug Discovery Business (2020-2025) & (US$ Million)
 Table 111. XRQTC Recent Development
 Table 112. Pharmaron Company Details
 Table 113. Pharmaron Business Overview
 Table 114. Pharmaron Computational Drug Discovery Product
 Table 115. Pharmaron Revenue in Computational Drug Discovery Business (2020-2025) & (US$ Million)
 Table 116. Pharmaron Recent Development
 Table 117. Research Programs/Design for This Report
 Table 118. Key Data Information from Secondary Sources
 Table 119. Key Data Information from Primary Sources
 Table 120. Authors List of This Report


List of Figures
 Figure 1. Computational Drug Discovery Picture
 Figure 2. Global Computational Drug Discovery Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Computational Drug Discovery Market Share by Type: 2024 VS 2031
 Figure 4. Structure-based Drug Design (SBDD) Features
 Figure 5. Ligand-based Drug Design (LBDD) Features
 Figure 6. Sequence-based Approaches Features
 Figure 7. Global Computational Drug Discovery Market Size by Application (2020-2031) & (US$ Million)
 Figure 8. Global Computational Drug Discovery Market Share by Application: 2024 VS 2031
 Figure 9. Oncological Disorders Case Studies
 Figure 10. Neurological Disorders Case Studies
 Figure 11. Immunological Disorders Case Studies
 Figure 12. Infectious Diseases Case Studies
 Figure 13. Others Case Studies
 Figure 14. Computational Drug Discovery Report Years Considered
 Figure 15. Global Computational Drug Discovery Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 16. Global Computational Drug Discovery Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 17. Global Computational Drug Discovery Market Share by Region: 2024 VS 2031
 Figure 18. Global Computational Drug Discovery Market Share by Players in 2024
 Figure 19. Global Top Computational Drug Discovery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Computational Drug Discovery as of 2024)
 Figure 20. The Top 10 and 5 Players Market Share by Computational Drug Discovery Revenue in 2024
 Figure 21. North America Computational Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. North America Computational Drug Discovery Market Share by Country (2020-2031)
 Figure 23. United States Computational Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Canada Computational Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Computational Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Europe Computational Drug Discovery Market Share by Country (2020-2031)
 Figure 27. Germany Computational Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. France Computational Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. U.K. Computational Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Italy Computational Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Russia Computational Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Nordic Countries Computational Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Computational Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Asia-Pacific Computational Drug Discovery Market Share by Region (2020-2031)
 Figure 35. China Computational Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Japan Computational Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. South Korea Computational Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Southeast Asia Computational Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. India Computational Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Australia Computational Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Computational Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Latin America Computational Drug Discovery Market Share by Country (2020-2031)
 Figure 43. Mexico Computational Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Brazil Computational Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Computational Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Middle East & Africa Computational Drug Discovery Market Share by Country (2020-2031)
 Figure 47. Turkey Computational Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Saudi Arabia Computational Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. UAE Computational Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. AMRI Revenue Growth Rate in Computational Drug Discovery Business (2020-2025)
 Figure 51. Charles River Revenue Growth Rate in Computational Drug Discovery Business (2020-2025)
 Figure 52. Schrödinger Revenue Growth Rate in Computational Drug Discovery Business (2020-2025)
 Figure 53. Evotec Revenue Growth Rate in Computational Drug Discovery Business (2020-2025)
 Figure 54. Bayers Revenue Growth Rate in Computational Drug Discovery Business (2020-2025)
 Figure 55. GVK Biosciences Revenue Growth Rate in Computational Drug Discovery Business (2020-2025)
 Figure 56. AstraZeneca Revenue Growth Rate in Computational Drug Discovery Business (2020-2025)
 Figure 57. BioDuro Revenue Growth Rate in Computational Drug Discovery Business (2020-2025)
 Figure 58. BOC Sciences Revenue Growth Rate in Computational Drug Discovery Business (2020-2025)
 Figure 59. Aris Pharmaceuticals Revenue Growth Rate in Computational Drug Discovery Business (2020-2025)
 Figure 60. ChemDiv Revenue Growth Rate in Computational Drug Discovery Business (2020-2025)
 Figure 61. RTI International Revenue Growth Rate in Computational Drug Discovery Business (2020-2025)
 Figure 62. XRQTC Revenue Growth Rate in Computational Drug Discovery Business (2020-2025)
 Figure 63. Pharmaron Revenue Growth Rate in Computational Drug Discovery Business (2020-2025)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

Computer Aided Drug Discovery CADD Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Computer Aided Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Drug Modeling Softwares Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Computer aided Drug Discovery CADD Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Computational Medicine and Drug Designing Software Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global In Silico Drug Discovery Market Insights Forecast to 2030
Machine Learning in Drug Discovery and Development Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Drug Discovery Software Market Insights Forecast to 2030
Drug Discovery and Development Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Label Free Drug Discovery Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
AI Drug Discovery Platform Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
New Drug Modeling Solution Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Drug Discovery Informatics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Computer assisted Drug Design Platform Market Research Report 2024
AI Drug Discovery Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Virtual Drug Discovery Service Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global In Silico Clinical Trials Market Research Report 2025
Drug Discovery Enzymes Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Artificial Intelligence Discovers Molecules Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Oncology Drug Discovery Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions